A detailed history of Bowman & CO S.C. transactions in Dexcom Inc stock. As of the latest transaction made, Bowman & CO S.C. holds 6,677 shares of DXCM stock, worth $486,285. This represents 0.24% of its overall portfolio holdings.

Number of Shares
6,677
Previous 5,924 12.71%
Holding current value
$486,285
Previous $671,000 33.38%
% of portfolio
0.24%
Previous 0.4%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$64.0 - $116.06 $48,192 - $87,393
753 Added 12.71%
6,677 $447,000
Q2 2024

Jul 24, 2024

BUY
$110.31 - $140.45 $58,133 - $74,017
527 Added 9.76%
5,924 $671,000
Q1 2024

Apr 15, 2024

BUY
$114.22 - $140.1 $616,445 - $756,119
5,397 New
5,397 $748,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bowman & CO S.C. Portfolio

Follow Bowman & CO S.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowman & CO S.C., based on Form 13F filings with the SEC.

News

Stay updated on Bowman & CO S.C. with notifications on news.